Learning Objectives:

Identify factors that impact immune checkpoint blockade efficacy in solid tumors.
Understand the role of single-cell and spatial biology techniques in revealing tumor immune heterogeneity at the patient level.
Explore systems biology approaches that leverage genome-wide spatial biology to predict immune checkpoint blockade efficacy in lung cancer.
Session date: 
01/13/2025 - 12:00pm to 1:00pm CST
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or create an account to proceed.
Speaker Name: 
Vivek Behera, MD PhD